[Antireflux hepaticojejunostomy in treatment of cancer of the head of pancreas or extrahepatic bile-ducts].
193 patients with obstructive jaundice were operated on during the period of 1987-2007 yy. Antireflux hepaticojejunostomy was performed in all cases. 124 (64,2%) patients experienced the radical treatment and 69 (35,8%) - palliative. Valve hepaticojejunoanastomosis was performed when hepatic duct length was 12-15 mm; weather hepatic duct was shorter then 12 mm, the valve was performed in efferent jejunal loop. Preoperative bile ducts decompression allowed decrease risk of hepatic failure and shorten the hospital-stay time after the major operation.
Zherlov
G K
GK
Karpovich
A V
AV
Zykov
D V
DV
Krasnoperov
A V
AV
Demakov
M V
MV
D000328:Adult; D000368:Aged; D000714:Anastomosis, Surgical; D001650:Bile Duct Neoplasms / Q000150:complications / Q000601:surgery*; D002761:Cholangitis / Q000517:prevention & control*; D003135:Common Bile Duct / Q000601:surgery; D003627:Data Interpretation, Statistical; D005260:Female; D006500:Hepatic Duct, Common / Q000601:surgery*; D006801:Humans; D041781:Jaundice, Obstructive / Q000209:etiology*; D007583:Jejunum / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000150:complications / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control*; D016896:Treatment Outcome